Diginova Health Solutions, a digital healthcare start-up based at the  DIFC, announced today its partnership with Finnish firm Cardiolyse,  to bring its award-winning cloud ECG & HRV analytics platform in  the UAE. Cardiolyse is an ECG & HRV predictive analytics platform for real-time remote heart health and fatigue risks monitoring, providing plain personalised reports, detection and up to two  months data-based prognosis on dangerous heart events. 

“An estimated 80% of cardiovascular disease (CVD), including heart  disease and stroke, are preventable, but sadly it remains one of the  leading causes of death in the UAE and around the world. CVD  complications are accountable for more than 50% of all deaths among  people with diabetes, which unfortunately is a grim reality in the UAE, with  over a million people living with it”, says Dr. Sarper Tanli, Co-Founder and  CEO of Diginova Health Solutions.

Cardiolyse's proprietary patent-pending machine-learning algorithms  process all vital ECG parameters to create an alerting feature that  notifies both patient and his doctor on increased stroke or heart attack  risks, enabling the prevention of critical heart events up to two months  before they occur. As a device-agnostic cloud platform, Cardiolyse cuts  off the need for complicated time-consuming integration by pairing its  solution with any type of digital ECG device via universal API  (application programming interface). The ecosystem is comprised of  customized web dashboards for both patients and physicians, as well as  independent Android and iOS applications for each user type needs. 

"Global healthcare is in obvious and desperate need for disruptive  technologies, and we are grateful for the opportunity to partner with  Diginova in bringing Cardiolyse to the UAE to support the region’s digital transformation as it serves the emerging challenges of both healthcare  providers and personal health-conscious patients", commented Anna  Starynska, Co-Founder and CEO at Cardiolyse. "Our primary goal here is  to provide timely and data-driven insights for physicians and cardiologists  to support the cost-effective patient-centric diagnosticating approach and  more accurate self-care solutions for patients. 

Dr. Sarper adds, “The MENA digital healthcare space is severely  underserved, with per capita spending lagging behind EU and the US by  as much as 60%. Our job at Diginova is to identify gaps in the market and  facilitate digital health products and solutions through entrepreneurs and  accelerator programs. Through our partnership with Cardiolyse we are committed to amplify the impact and scale of digital heath solutions in the  region. 

Diginova also confirmed that the UAE launch of Cardiolyse will be followed  by a region-wide entry across the GCC, starting immediately with KSA.

About Diginova 

Diginova Health Solutions Ltd. is a digital health start-up founded in 2020 by Dr. Sarper  Tanli, a healthcare specialist with over 28 years of experience, including healthcare  investments and digital health implementation in the US and the Middle East, and Utku  Balik, an ex-strategy consultant and banker with over 18 years of experience in  strategy, business development and financial management. Diginova is registered in  Dubai International Financial Centre (DIFC). 

Diginova aims to become the leading platform that incubates, supports and invests in  the most promising digital health startups. It also closely collaborates with  governments, regulators and accelerators to improve the well-being of communities  in the Middle East and North Africa (MENA) region.  

About Cardiolyse 

Cardiolyse is an award-winning e-healthcare start-up company based in the EU. It  specialises in delivering holistic approach in preventing heart disorders for elevated risk  groups, using innovative and clinically proven machine-learning algorithms. 

It was founded in 2016 by Anna Starynska, a computer science and applied  technologies expert and a distinguished project manager with more than 25 years of  experience in leading multinational complex projects across the EU; and by Dr. Illya  Chaikovsky, a published scientist, with more than 30 years of experience in practicing cardiology. 

Cardiolyse is the WINNER of the AMGEN Challenge of 2020 EIT Health Startups  Meet Pharma. The Amgen Challenge is dedicated to encouraging continuity in  treatment strategy and treatment optimization for post-myocardial infraction patients. 

For more information visit cardiolyse.com